Geriatrics
Quality of life is not a treatment selection factor for older cancer patients
Published in Cancer Weekly, June 15th, 2004
According to recent research from the United States, "older patients with acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (aMDS) must decide between receiving intensive induction chemotherapy (IC) or nonintensive chemotherapy/best supportive care (NIC). Little information exists about what factors influence treatment decisions and what quality of life (QOL) is associated with treatment choices. We prospectively examined 43 patients 60 years or older who were interviewed at diagnosis and periodically over 1 year."
"IC choice was associated with younger...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-06-15)
More Articles from Cancer Weekly
- Cancer Risk Factor
Agents formed when red meat is cooked may be responsible for rectal cancer - Cancer Therapy
Recurrent multiple myelomas respond to an oral combined drug regimen - Endocrinology
Phytoestrogens may disturb the estrogen balance in human tissues - Enzyme Suppression
Tc-99m-labeled celebrex traces the biodistribution of COX-2 in tumors - Metastasis
Repeat radiotherapy offers children with metastatic bone cancer palliation - Acute Lymphoid Leukemia
Combinatorial gene therapy offers antitumor protection to leukemia models - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
